10 results
POS AM
LSB
LakeShore Biopharma Co., Ltd
23 Jan 24
Prospectus update (post-effective amendment)
4:18pm
rabies vaccine market production value.
China’s Rabies Vaccine Market Production Value, 2017 — 2030E
Source: Expert interview, Frost & Sullivan analysis … the lot release quantity of human rabies vaccine by estimated total number of rabies vaccines required theoretically.
Source: Expert interview, NIFDC
424B3
LSB
LakeShore Biopharma Co., Ltd
15 Aug 23
Prospectus supplement
8:00am
market production value.
China’s Rabies Vaccine Market Production Value, 2017 - 2030E
Source: Expert interview, Frost & Sullivan analysis
There are two … quantity of human rabies vaccine by estimated total number of rabies vaccines required theoretically.
Source: Expert interview, NIFDC, Frost & Sullivan
POS AM
LSB
LakeShore Biopharma Co., Ltd
8 Aug 23
Prospectus update (post-effective amendment)
4:06pm
rabies vaccine market production value.
China’s Rabies Vaccine Market Production Value, 2017 - 2030E
Source: Expert interview, Frost & Sullivan … the lot release quantity of human rabies vaccine by estimated total number of rabies vaccines required theoretically.
Source: Expert interview
20-F
2023 FY
LSB
LakeShore Biopharma Co., Ltd
26 Jul 23
Annual report (foreign)
4:02pm
regimen upon the completion of the NDA. This vaccine candidate was designated by a WHO expert committee background paper publication as an innovative … for both pre- and post-exposure rabies prophylaxis and was designated by a WHO expert committee document as innovative rabies vaccine in 2017
424B3
0331az4z7hm4
5 Jun 23
Prospectus supplement
4:03pm
F-1/A
l2a1sl l7o54
12 May 23
Registration statement (foreign) (amended)
4:05pm
F-1
xpomtpxahzw7sfyhmkze
12 Apr 23
Registration statement (foreign)
8:49am
F-4
EX-10.6
7jc07f3126y73y6
28 Dec 22
Registration of securities (foreign)
6:58am
425
EX-99.2
2gt99l8g
30 Sep 22
Business combination disclosure
9:25am
- Prev
- 1
- Next